PHARMACEUTICS AND LIFE SCIENCE

Novo Nordisk Partners with Vivtex in Up to $2.1B Oral O..

Novo Nordisk partnered with MIT spinout Vivtex in a deal worth up to $2.1 billion to develop next-generation oral biologic drugs for obesity and diabe...

Pharma Firms Left Out of Trump Drug Deals Seek Entry..

Drugmakers excluded from the Trump administration’s latest drug-pricing agreements are lobbying for inclusion, fearing competitive disadvantage ...

HHS Resets National Autism Panel with 21 New Members..

HHS Secretary Kennedy has appointed 21 new members to the Interagency Autism Coordinating Committee, resetting federal research and services policy. ...

AbbVie Plans Major Buildout in Competitive Obesity Drug..

Pharmaceutical giant AbbVie announces strategic plans to expand its presence and pipeline in the high-stakes, fast-growing market for obesity medicati...

Biosecure Act Heads to Trump's Desk in Defense Bill..

The Biosecure Act, targeting Chinese biotech firms, is headed to President Trump's desk as part of the annual defense spending bill. The Biosecu...